Pharmalot… Pharmalittle… Good Morning
Make a commentBy Ed Silverman // March 3rd, 2010 // 8:12 am
Hello, and nice to see you again. A spot of rain here on the Pharmalot corporate campus, but as always, we manage to keep our spirits sunny. Of course, we get help from a cup or two of stimulation, but you already know that. Meanwhile, another day lies ahead and all sorts of adventures await. To help you navigate, here are a few items of interest. Have a good one….
Pfizer Alzheimer’s Drug Fails Phase III Study (Associated Press)
Bristol And Allergan Sign Deal For Pain Drug (Reuters)
Pfizer To Make Bid For Ratiopharm (Bloomberg News)
UK’s NICE Recommends Roche’s RA Drug (Reuters)
Leave a Comment
Subscribe
Comments feed for this post only.
Tags
Alzheimers, Dimebon, MabThera, Medivation, NICE, Pfizer, Ratiopharm, Rituximab, Roche